Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Sangamo Therapeutics, Inc. SGMO

Full chart Compare
Set alert

Price alert · SGMO

All alert types
0.07 USD 0.00 (+0.00%)

At closeJul 1, 2026, 4:00 PM EDT

0.15 +0.07 +98.38%

After hours · Jul 1, 4:00 PM ET

0.0637 Day range 0.13

52-week range unavailable

YTD
-82.38%
1 year
-87.29%

Financial health

Altman Z-Score

-2429.41 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2016: -3.0×FY 2017: -23.4×FY 2018: -16.4×FY 2019: -12.3×FY 2020: -17.3×FY 2021: -6.1×FY 2022: -2.5×FY 2023: -0.4×FY 2024: -2.1×FY 2025: -1.0×
FY 2016 5y median -2.1× FY 2025
P/S 3.0×
FY 2016: 11.1×FY 2017: 35.0×FY 2018: 13.2×FY 2019: 9.2×FY 2020: 17.8×FY 2021: 9.8×FY 2022: 4.4×FY 2023: 0.5×FY 2024: 3.6×FY 2025: 3.0×
FY 2016 5y median 3.6× FY 2025
P/B -8.2×
FY 2016: 1.6×FY 2017: 6.8×FY 2018: 3.0×FY 2019: 2.2×FY 2020: 4.2×FY 2021: 2.9×FY 2022: 1.6×FY 2023: 1.1×FY 2024: 9.0×FY 2025: -8.2×
FY 2016 5y median 1.6× FY 2025
P/FCF -1.2×
FY 2016: -3.2×FY 2017: 172×FY 2018: -188×FY 2019: -5.7×FY 2020: 13.5×FY 2021: -4.2×FY 2022: -2.0×FY 2023: -0.4×FY 2024: -3.1×FY 2025: -1.2×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA -1.1×
FY 2016: -2.8×FY 2017: -22.9×FY 2018: -13.4×FY 2019: -9.4×FY 2020: -17.3×FY 2021: -5.9×FY 2022: -2.5×FY 2023: -0.9×FY 2024: -2.2×FY 2025: -1.1×
FY 2016 5y median -2.2× FY 2025
EV/Sales 3.1×
FY 2016: 10.2×FY 2017: 34.3×FY 2018: 11.8×FY 2019: 8.8×FY 2020: 17.0×FY 2021: 8.6×FY 2022: 3.8×FY 2023: 0.5×FY 2024: 3.4×FY 2025: 3.1×
FY 2016 5y median 3.4× FY 2025
FCF Yield -82.7%
FY 2016: -31.0%FY 2017: 0.6%FY 2018: -0.5%FY 2019: -17.6%FY 2020: 7.4%FY 2021: -23.7%FY 2022: -50.3%FY 2023: -259.6%FY 2024: -32.8%FY 2025: -82.7%
FY 2016 5y median -50.3% FY 2025

Profitability

Gross Margin 80.8%
FY 2016: -238.4%FY 2017: -79.7%FY 2018: -36.0%FY 2019: -42.5%FY 2020: -52.8%FY 2021: 100.0%FY 2022: 89.1%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 80.8%
FY 2016 5y median 100.0% FY 2025
Operating Margin -273.1%
FY 2016: -374.2%FY 2017: -154.1%FY 2018: -91.4%FY 2019: -102.7%FY 2020: -109.6%FY 2021: -165.6%FY 2022: -180.8%FY 2023: -155.5%FY 2024: -179.9%FY 2025: -273.1%
FY 2016 5y median -179.9% FY 2025
Net Margin -310.8%
FY 2016: -369.6%FY 2017: -149.2%FY 2018: -80.9%FY 2019: -92.9%FY 2020: -102.4%FY 2021: -161.1%FY 2022: -172.8%FY 2023: -146.3%FY 2024: -169.4%FY 2025: -310.8%
FY 2016 5y median -169.4% FY 2025
ROE 861.6%
FY 2016: -52.6%FY 2017: -29.0%FY 2018: -18.6%FY 2019: -22.0%FY 2020: -24.3%FY 2021: -47.5%FY 2022: -65.2%FY 2023: -311.1%FY 2024: -430.1%FY 2025: 861.6%
FY 2016 5y median -65.2% FY 2025
ROIC -566.4%
FY 2016: -50.2%FY 2017: -23.3%FY 2018: -15.1%FY 2019: -18.4%FY 2020: -16.2%FY 2021: -30.7%FY 2022: -44.2%FY 2023: -219.9%FY 2024: -172.6%FY 2025: -566.4%
FY 2016 5y median -172.6% FY 2025
ROA -205.8%
FY 2016: -45.4%FY 2017: -19.0%FY 2018: -11.6%FY 2019: -14.9%FY 2020: -12.9%FY 2021: -24.7%FY 2022: -34.2%FY 2023: -156.0%FY 2024: -96.4%FY 2025: -205.8%
FY 2016 5y median -96.4% FY 2025

Growth (YoY)

Revenue -31.6%
FY 2016: -51.0%FY 2017: 88.6%FY 2018: 131.0%FY 2019: 21.3%FY 2020: 15.4%FY 2021: -6.3%FY 2022: 0.5%FY 2023: 58.3%FY 2024: -67.2%FY 2025: -31.6%
FY 2016 FY 2025
Operating Income -3.9%
FY 2016: -54.9%FY 2017: 22.3%FY 2018: -36.9%FY 2019: -36.3%FY 2020: -23.2%FY 2021: -41.5%FY 2022: -9.8%FY 2023: -36.1%FY 2024: 62.1%FY 2025: -3.9%
FY 2016 FY 2025
EPS (diluted) 10.2%
FY 2016: -75.9%FY 2017: 31.4%FY 2018: 0.0%FY 2019: 2.9%FY 2020: -32.4%FY 2021: -36.7%FY 2022: -1.6%FY 2023: -18.4%FY 2024: 66.9%FY 2025: 10.2%
FY 2016 FY 2025
Free Cash Flow -44.4%
FY 2016: -84.4%FY 2017: 111.2%FY 2018: -179.6%FY 2019: -2691.8%FY 2020: 194.0%FY 2021: -265.3%FY 2022: 5.0%FY 2023: -0.9%FY 2024: 72.6%FY 2025: -44.4%
FY 2016 FY 2025

Financial Health

Current Ratio 0.8×
FY 2016: 11.3×FY 2017: 5.5×FY 2018: 5.2×FY 2019: 5.8×FY 2020: 4.6×FY 2021: 3.1×FY 2022: 2.7×FY 2023: 2.0×FY 2024: 1.1×FY 2025: 0.8×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 0.8×
FY 2016: 11.3×FY 2017: 5.6×FY 2018: 5.2×FY 2019: 5.8×FY 2020: 4.6×FY 2021: 3.1×FY 2022: 2.7×FY 2023: 2.0×FY 2024: 1.1×FY 2025: 0.8×
FY 2016 5y median 2.0× FY 2025
Debt / Equity -1.9×
FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.5×FY 2024: 1.3×FY 2025: -1.9×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: 0.3×FY 2017: 0.5×FY 2018: 1.5×FY 2019: 0.4×FY 2020: 0.8×FY 2021: 0.8×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.1×FY 2025: -0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31